MedTrace Logo

Conventional Versus Automated Bag-based Mechanical Ventilator to Support ARDS Patients

NCT06667375 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2024-10-31

No results posted yet for this study

Summary

This study evaluates the extubation success and compares the survival rate in patients with signs of Covid-19 intubated with Masi, a novel type of mechanical ventilator, or with other conventional ventilators admitted in the ICU of a reference hospital in Lima, Peru between January and August 2021. The Masi mechanical ventilator works by automating a resuscitation bag with promising preclinical results. The key features of Masi are its low manufacturing cost, low dependence on a supply of high volumes of oxygen, low oxygen consumption, flexibility between non-invasive and invasive ventilation, and extended range of working environmental altitudes compared to commercially available ventilators. A retrospective study of variables and outcomes was done. The main goal of this study is to compare the survival rate of respiratory failure patients supported either with Masi or conventional ventilators at Hospital Vitarte II in Lima between January and August 2021.

Conditions

  • Acute Respiratory Distress Syndrome (ARDS)

Sponsors & Collaborators

  • EsSalud Hospital Vitarte (HOSPITAL II VITARTE ESSALUD)

    collaborator UNKNOWN

  • Fanny Lys Casado Pena

    lead OTHER

Principal Investigators

  • Fanny L Casado Peña, PhD · Pontificia Universidad Catolica del Peru

  • Sergio Sánchez-Gambetta, MD, MSc · Pontificia Universidad Catolica del Peru

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-19
Primary Completion
2021-08-27
Completion
2022-12-20

Countries

  • Peru

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06667375 on ClinicalTrials.gov